SBI Life Insurance's Q1 FY26 results reveal a strategic product mix shift driving VNB margin growth amid cost discipline and regulatory vigilance in India's insurance sector.

HCA Healthcare's Q2 2024 earnings demonstrate strategic growth fueled by digital transformation, aging demographics, and expansion into non-acute care. Strong financial metrics and operational discipline highlight market leadership.

Explore why Lincoln National, Lemonade, and AXIS Capital stocks require caution in portfolios amid market gains and risk exposures in the insurance sector.

Explore how Marsh & McLennan Companies leverages diversification and acquisitions to maintain growth and profitability amid softening insurance pricing and rising liability costs.

Clover Health launches a New Jersey pharmacy pilot targeting medication adherence and hospitalization cuts to improve Medicare Advantage margins and unlock growth potential.

Lemonade expands into Indiana's $5B auto insurance market leveraging AI, telematics, and bundling strategies to drive premium growth and approach profitability by 2026.

Centene's financial guidance withdrawal due to rising costs causes a 40% stock drop, impacting the health insurance sector and investor confidence.

Ategrity Specialty Holdings initiates IPO priced $14-$16 per share to bolster capital and expand specialty P&C insurance operations, reporting strong net income growth for 2024.

UnitedHealth faces DOJ investigation and Medicare scrutiny amid rising medical costs, yet diversification through Optum supports potential recovery in 2025.

F&G Annuities & Life reported a Q1 2025 net loss of $25M but achieved a record $67.4B in assets under management, fueled by indexed annuity sales and strong capital management.